Home/bioRASI/Chris O'Brien
CO

Chris O'Brien

CEO

bioRASI

bioRASI Pipeline

DrugIndicationPhase
Osmolex ERParkinson's Disease; Drug-induced extrapyramidal reactionsApproved
ASD Diagnosis AidDiagnosis of Autism Spectrum Disorder (ASD) in pediatric patientsApproved
Empaveli (pegcetacoplan)Paroxysmal Nocturnal Hemoglobinuria (PNH)Approved